📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience. (2021)

First Author: Shields AM

Attributed to: Gene Editing in X-Linked Agammaglobulinaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2020.12.620

PubMed Identifier: 33338534

Publication URI: http://europepmc.org/abstract/MED/33338534

Type: Journal Article/Review

Volume: 147

Parent Publication: The Journal of allergy and clinical immunology

Issue: 3

ISSN: 0091-6749